*New*
• New CWT manual - new version being published
The new CWT manual i.e. update to v6.5 will be published in mid-March 2010 and will be available here.
• Breach re-allocation form 2008/09 – can we still use?
Response from Care Quality Commission regarding the breach re-allocation form:
http://www.cqc.org.uk/_db/_documents/Reallocation_form_200904291418.doc
Currently the policy only applies to non-administrative delays at the referring trust and where the treating trust has received the patient on or after day 63. The current form specifically applies to the 2008/09 year and we are working on the new version which will apply to 2009/10. While we are happy to accept agreements for 2009/10 using the 2008/09 forms, it would be preferable for trusts to await the new forms in case there are any changes agreed. The deadline for CQC to receive reallocation requests for 2009/10 will not be until late June 2010, so as long as trusts can maintain records of shared breaches there is no immediate rush to submit them to us.
• Cancer Waiting Times standards
The DH have agreed the new operational standards for cancer waits as follows:
| Existing Standards | Operational Standard |
| 14 day standard | 93% |
| 62 day standard | 85% |
| 31 day standard | 96% |
| New Standards | |
| 62 day screening standard | 90% |
| 62 day consultant upgrade standard | Not yet set |
| 31 day drug standard | 98% |
| 31 day surgery standard | 94% |
| 31 day radiotherapy standard (from Dec 2010) | 94% |
| Breast 14 day symptomatic standard (from Dec 2009) | 93% |
Data upload
• Uploading of data for breast symptoms and radiotherapy
Data relating to breast symptoms and radiotherapy is required for upload to Open Exeter by the deadline of 19 May 09. However, whilst is required, they not assessed in the AHC 2008/9
How do you ensure that the patient pathway identifier can be transferred robustly from one trust to another?
There is an inter provider trust dataset that has been mandated for 18 weeks – this should ensure all the info required is transferred across.
• Open Exeter Report Dates 2010 (updated)
| Month | Quarterly Reports | Upload Deadline | Generation Date |
| January 2010 | Friday, 5 March 2010 | Monday, 8 March 2010 | |
| February 2010 | Tuesday, 6 April 2010 | Wednesday, 7 April 2010 |
|
| March 2010 | Q4 2009-2010 | Monday, 10 May 2010 | Tuesday, 11 May 2010 |
| April 2010 | Tuesday, 8 June 2010 | Wednesday, 9 June 2010 |
|
| May 2010 | Monday, 5 July 2010 | Tuesday, 6 July 2010 |
|
| June 2010 | Q1 2010-2011 | Wednesday, 4 August 2010 | Thursday, 5 August 2010 |
| July 2010 | Monday, 6 September 2010 | Tuesday, 7 September 2010 |
|
| August 2010 | Tuesday, 5 October 2010 | Wednesday, 6 October 2010 |
|
| September 2010 | Q2 2010-2011 | Thursday, 4 November 2010 | Friday, 5 November 2010 |
| October 2010 | Friday, 3 December 2010 | Monday, 6 December 2010 |
Subsequent treatments
• Multi-modality treatment plan – what counts as a subsequent treatment?
Data relating to breast symptoms and radiotherapy is required for upload to Open Exeter by the deadline of 19 May 09. However, whilst is required, they not assessed in the AHC 2008/9.
If a package of care is agreed e.g. surgery followed by radiotherapy followed by chemotherapy for breast cancer - the surgery would be the FDT and the radiotherapy a subsequent treatment and the chemo another subsequent treatment.
The exception would be chemo-radiation which is classed as a single treatment and coded as such in the dataset - for this it would start on the date the first of these treatments is given.
Screening referrals
All trusts should be moving to direct referrals from the cytology lab to colposcopy.
Patients with moderate or severe dyskaryosis (or invasive cancer glandular neoplasia) will be on a 62 day pathway. These referrals for colostomy indicate at least CIN or a suspicion of cancer.
These screening referrals are not covered by the 2ww standard and there is no national target for time to first seen for these patients so this portion of the pathway will not be monitored as a standard centrally.
However, there are internal QA waits standards within the screening programme and if these internal standards are met, the vast majority of patients diagnosed with cancer via the screening programmes will be able to receive their first treatment within 62 days of receipt of referral if they were clinically fit and wanted to be treated within this timescale.
For direct referrals, day 0 is receipt of referral (i.e. when the colposcopy dept receives the referral direct from the cytology lab).
Where patients are not directly referred to lab i.e. the referrals go via the GP the patients would no longer be part of the screening cohort i.e. if the GP does a 2ww referral they are part of the original 2ww / 62 day pathway as they always had been prior to GFOCW (day 0 starts with receipt of referral by colposcopy etc.).
If the patient had low risk cytology the screening programme would refer back to the GP. The GP would not need to do a 2ww referral for such patients but it would be possible to do a consultant upgrade of such a referral if the consultant suspected cancer despite the low risk cytology.
The host of the screening service i.e. the provider commissioned to do the colposcopy will be responsible for uploading up to DATE FIRST SEEN irrespective of whether or not the patient was diagnosed with cancer.
The organisation commissioned to treat the patient is responsible for uploading the second part of the pathway i.e. from decision to treat to first treatment?
If a patient is directly referred from cytology to colposcopy in Trust A, but they then subsequently decide to choose to be first seen at another Trust B, then the Trust where the patient is first seen i.e. the one commissioned to provide the service should upload the data.
The DATE FIRST SEEN refers to first appointment following referral (or recall) from (or by) a screening provider i.e. appointment for colpsocopy.
The starting point for the 62 day standard is ORIGINAL REFERRAL REQUEST RECEIVED DATE i.e. receipt of referral for a colposcopy appointment
Within NLCN, the North London Breast Screening Service (NLBSS) is the screening centre. The 62 day pathway starts when the referral is both made and received within the screening service i.e. day 0 starts in NLBSS.
It is the responsibility of the host organisation that has been commissioned to provide the service to upload all records up to DATE FIRST SEEN.
The host trust for NLBSS is Barnet and Chase Farm Trust, so BCF would need to upload these records on behalf of NLBSS, with appropriate mechanisms in place to capture and transfer this data between the two organisations.
To distinguish these patients from those seen in BCF’s capacity as a conventional NHS provider, code 17 (a National Screening Programme) should be used in SOURCE OF REFERRALS FOR OUTPATIENTS.
The organisation commissioned to treat the patient is responsible for uploading the second part of the pathway i.e. from decision to treat to first treatment.
For example, Barnet & Chase Farm as the host provider is commissioned to provide the breast screening service; they are responsible for uploading the data up to DATE FIRST SEEN.
If BCF has been commissioned to provide the treatment they are responsible for uploading this activity.
Performance figures would appear under the accountable provider ie. if the provider was commissioned to see the patient (DATE FIRST SEEN) and treat the patient (TREATMENT START DATE (CANCER)) the ‘whole’ patient is recorded against their organisation. If they were only responsible for one part of the pathway (ie. just DATE FIRST SEEN or just TREATMENT START DATE (CANCER)) then they will be responsible for 0.5 of the patient ie. performance is apportioned.
The DATE FIRST SEEN refers to first appointment following referral (or recall) from (or by) a screening provider i.e. appointment for further assessment following screening mammogram. In North London, this happens within NLBSS.
Within the NCLN, the bowel screening centre is University College Hospital.
• Provides endoscopy service and specialist screening nurse clinics
• Provides alternative investigations where colonoscopy is not appropriate
• Provides pathology (histology) services
• Refers those requiring treatment for cancer to their local hospital multi-disciplinary team (MDT)
GPs are not directly involved in the delivery of the NHS Bowel Cancer Screening Programme but they will be notified when invitations for bowel cancer screening are being sent out in their area. They will also receive a copy of the results letters sent to their patients.
It is the responsibility of the host organisation that has been commissioned to provide the service to upload all records up to DATE FIRST SEEN.
The host trust for bowel screening is University College Hospital and they will be responsible for uploading until DATE FIRST SEEN.
The organisation commissioned to treat the patient is responsible for uploading the second part of the pathway i.e. from decision to treat to first treatment.
| Attachment | Size |
|---|---|
| NCAT GFOCW Q and A - November 2009.pdf | 228.06 KB |
![]()
© The North London Cancer Network 2008